Please check your internet connection and try again.
# Miconazole vaginal pessary
## Overview
Miconazole is an imidazole antifungal agent effective against a variety of yeasts and fungi. The vaginal pessary is formulated for local administration to treat vaginal fungal infections.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg pessary:** Insert one pessary vaginally once daily at bedtime for 7 days.
* **200 mg pessary:** Insert one pessary vaginally once daily at bedtime for 3 days.
* **Intravaginal gel (if available as a pessary alternative):** Typically 5 grams inserted vaginally once daily at bedtime for 7 days.
## Pediatric Dosing
Safety and efficacy in pediatric patients (under 12 years) have not been established for the vaginal pessary. Consult product labeling or specialist guidance.
## Dose Adjustments
No dose adjustments are typically required based on renal or hepatic impairment due to minimal systemic absorption.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
* Concomitant use with CYP3A4 substrates (e.g., certain statins, benzodiazepines, calcium channel blockers) due to increased risk of adverse effects. Review medication list carefully.
## Adverse Effects
Common adverse effects include vaginal itching, burning, irritation, and abdominal cramping. Less common: headache, rash.
## Key Drug Interactions
* **CYP3A4 Inhibitors:** Miconazole is a moderate inhibitor of CYP3A4. Concomitant use with CYP3A4 substrates can lead to increased plasma concentrations and potential toxicity of the substrate. Examples include:
* Certain statins (e.g., simvastatin, atorvastatin)
* Certain benzodiazepines (e.g., midazolam, triazolam)
* Certain calcium channel blockers (e.g., nifedipine)
* Warfarin (increased anticoagulant effect)
* **Disulfiram:** Concurrent use with alcohol-containing products (including some vaginal preparations) may cause a disulfiram-like reaction.
## Monitoring
* Monitor for resolution of symptoms (e.g., itching, discharge).
* Assess for signs of local irritation or allergic reaction.
* If symptoms persist after completing therapy, consider alternative treatments or re-evaluation for other causes of vaginitis.
## Clinical Pearls
* Pessaries should be inserted high into the vagina.
* Advise patients to avoid sexual intercourse during treatment to prevent potential irritation or reduced efficacy.
* Treatment may be continued during menstruation, but some may prefer to complete therapy before or after menses.
* Ensure patient understands the importance of completing the full course of treatment, even if symptoms improve earlier.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and local protocols for complete details and to ensure patient safety.*
